Posted 1/15/2008 7:00 AM (GMT -6)
Salix Pharmaceuticals, Ltd. SLXP today announced that, pursuant to a supply and distribution agreement with Watson Pharma, Inc., Watson will market and sell an authorized generic of COLAZAL(R) (balsalazide disodium) Capsules 750 mg, the Company's anti-inflammatory drug approved for the treatment of mildly to moderately active ulcerative colitis. Watson will launch the authorized generic product immediately. December 28, 2007 article
So I'm assuming they're just waiting for the distribution agreement. So it should be any day now!